Clinical Research Directory
Browse clinical research sites, groups, and studies.
MINIject Global Long-Term Follow-up Study
Sponsor: iSTAR Medical
Summary
The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.
Official title: A Prospective, Open, Multicentre Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2020-08-05
Completion Date
2025-12
Last Updated
2025-02-28
Healthy Volunteers
No
Conditions
Interventions
Minimally invasive glaucoma surgery (MIGS)
MINIject implant placed into supraciliary space. The implantation was done in a previous study in which patient participated and is not part of this study.
Locations (9)
Clinica Oftalmologica del Caribe
Barranquilla, Colombia
Center Hospotalier Universitaire Genoble Alpes
Grenoble, France
Hopital de la Croix-Rousse
Lyon, France
Uniklinik Köln
Cologne, North Rhine-Westphalia, Germany
Universitätsklinikum Mainz
Mainz, Rhineland-Palatinate, Germany
Klinikum der Universität München
München, Germany
Maxivision Eye Hospital
Hyderabad, Telangana, India
Panama Eye Center
Panama City, Panama
Hospital Clínico San Carlos
Madrid, Spain